Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Kuwabara, Takashige ^a   Mori, Kiyoshi ^a   Kasahara, Masato ^a,b   Yokoi, Hideki ^a   Imamaki, Hirotaka ^a   Ishii, Akira ^a   Koga, Kenichi ^a   Sugawara, Akira ^c   Yasuno, Shinji ^b   Ueshima, Kenji ^b   Morikawa, Takashi ^d   Konishi, Yoshio ^d   Imanishi, Masahito ^d   Nishiyama, Akira ^e   Nakao, Kazuwa ^a   Mukoyama, Masashi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c OSAKA RED CROSS HOSPITAL   (Japan)

^d OSAKA CITY GENERAL HOSPITAL   (Japan)

^e KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CD68 ANTIGEN; INTERLEUKIN 1BETA; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; ARTICLE; ATROPHY; CELL COUNT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLOMERULUS EPITHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY BIOPSY; KIDNEY FIBROSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; MRP8 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEINURIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; ANIMAL; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KIDNEY DISEASES; METABOLISM; MIDDLE AGED; URINE;

ADULT; ANIMALS; CALGRANULIN A; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; KIDNEY DISEASES; MACROPHAGES; MALE; MIDDLE AGED; OBESITY; PROGNOSIS;

EID: 84895885712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088942     Document Type: Article

References (30)

1. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98-107.
2. Odink K, Cerletti N, Bruggen J, Clerc RG, Tarcsay L, et al. (1987) Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80-82. (Pubitemid 17152420)
3. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, et al. (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13: 1042-1049. (Pubitemid 47517513)
4. Croce K, Gao H, Wang Y, Mooroka T, Sakuma M, et al. (2009) Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 120: 427-436.
5. Loser K, Vogl T, Voskort M, Lueken A, Kupas V, et al. (2010) The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8 + T cells. Nat Med 16: 713-717.
6. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, et al. (2012) Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia 55: 2256-2266.
7. Fujiu K, Manabe I, Nagai R (2011) Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest 121: 3425-3441.
8. Sekimoto R, Kishida K, Nakatsuji H, Nakagawa T, Funahashi T, et al. (2012) High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice. Biochem Biophys Res Commun 419: 782-789.
9. Mortensen OH, Nielsen AR, Erikstrup C, Plomgaard P, Fischer CP, et al. (2009) Calprotectin - a novel marker of obesity. PLoS One 4: e7419.
10. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992.
11. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, et al. (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28: 164-176. (Pubitemid 40095801)
12. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59: 1498-1509. (Pubitemid 32281241)
13. Praga M, Morales E (2006) Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens 15: 481-486.
14. Kawasaki Y, Hosoya M, Takahashi A, Isome M, Tanji M, et al. (2005) Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1. Am J Kidney Dis 45: 510-518. (Pubitemid 40341330)
15. Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, et al. (2011) Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant 26: 170-177.
16. Ogawa Y, Mukoyama M, Yokoi H, Kasahara M, Mori K, et al. (2012) Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury. J Am Soc Nephrol 23: 1198-1209.
17. Yokoi H, Mukoyama M, Mori K, Kasahara M, Suganami T, et al. (2008) Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int 73: 446-455. (Pubitemid 351186294)
18. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752. (Pubitemid 29314747)
19. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, et al. (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27: 84-91. (Pubitemid 46370478)
20. Pepper RJ, Hamour S, Chavele KM, Todd SK, Rasmussen N, et al. (2013) Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis. Kidney Int 83: 1150-1158.
21. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R (1998) Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158: 998-1004. (Pubitemid 28213577)
22. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, et al. (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Bmj 321: 412-419. (Pubitemid 30609443)
23. Ruggenenti P, Remuzzi G (1998) Nephropathy of type-2 diabetes mellitus. J Am Soc Nephrol 9: 2157-2169. (Pubitemid 28482168)
24. Taft JL, Nolan CJ, Yeung SP, Hewitson TD, Martin FI (1994) Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 43: 1046-1051. (Pubitemid 24230711)
25. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, et al. (2012) Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 23: 1181-1189.
26. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, et al. (2009) Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 75: 285-294.
27. Kawasaki Y, Suyama K, Go H, Imamura T, Ushijima Y, et al. (2009) Accumulation of macrophages expressing myeloid-related protein 8 associated with the progression of sclerotic changes in children with IgA nephropathy. Tohoku J Exp Med 218: 49-55.
28. Nagareddy PR, Murphy AJ, Stirzaker RA, Hu Y, Yu S, et al. (2013) Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab 17: 695-708.
29. Jin Y, Sharma A, Carey C, Hopkins D, Wang X, et al. (2013) The Expression of Inflammatory Genes Is Upregulated in Peripheral Blood of Patients with Type 1 Diabetes. Diabetes Care.
30. Longo VD, Finch CE (2003) Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299: 1342-1346. (Pubitemid 36254638)